Annual Insider Trading Report

Cytek Biosciences, Inc. Filed 2022-02-14 Acc 0001209191-22-009458

Documents 1

2022-02-17 SC 13G Amended Statement of Ownership
2022-02-16 4 Director bought 498,629 shares at an average $14.89 ($7,426,825)
2022-02-14 4 Chief Technology Officer sold 20,000 shares at an average $15.11 ($302,106)
2022-02-14 5 Annual Insider Trading Report
2022-02-14 SC 13G Amended Statement of Ownership
2022-02-14 SC 13G Amended Statement of Ownership
2022-02-14 SC 13G Amended Statement of Ownership

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslF345X03/doc5.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…